Generation Bio 

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$765
$8,723
$4,188
$7,554
Gross Profit
765
8,723
4,188
7,554
EBITDA
-21,268
-14,332
-18,786
-15,535
EBIT
-22,402
-15,468
-19,962
-16,715
Net Income
-20,923
-14,802
-21,382
-15,313
Net Change In Cash
765
8,723
4,188
7,554
Free Cash Flow
-17,287
-28,606
-16,162
-19,638
Cash
49,094
50,891
76,301
21,657
Basic Shares
6,703
6,700
6,673
6,673

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$19,892
$5,904
$880
$0
Gross Profit
19,892
-71,035
-5,130
-4,532
EBITDA
-74,262
-133,300
-136,052
-114,569
EBIT
-79,193
-138,563
-141,182
-119,101
Net Income
-131,668
-126,612
-132,096
-114,669
Net Change In Cash
19,892
5,904
880
0
Cost of Revenue
-281,974
315,897
Free Cash Flow
-90,964
-60,142
-111,249
-97,779
Cash
76,301
66,446
93,171
375,145
Basic Shares
6,662
64,483
5,811
5,629

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$1.56
2025-03-31
-$0.20
2024-12-31
-$0.26